221 related articles for article (PubMed ID: 22910912)
1. Proline-mediated proteasomal degradation of the prostate-specific tumor suppressor NKX3.1.
Rao V; Guan B; Mutton LN; Bieberich CJ
J Biol Chem; 2012 Oct; 287(43):36331-40. PubMed ID: 22910912
[TBL] [Abstract][Full Text] [Related]
2. Ubiquitination by TOPORS regulates the prostate tumor suppressor NKX3.1.
Guan B; Pungaliya P; Li X; Uquillas C; Mutton LN; Rubin EH; Bieberich CJ
J Biol Chem; 2008 Feb; 283(8):4834-40. PubMed ID: 18077445
[TBL] [Abstract][Full Text] [Related]
3. Inflammatory cytokines induce phosphorylation and ubiquitination of prostate suppressor protein NKX3.1.
Markowski MC; Bowen C; Gelmann EP
Cancer Res; 2008 Sep; 68(17):6896-901. PubMed ID: 18757402
[TBL] [Abstract][Full Text] [Related]
4. Stabilization of the prostate-specific tumor suppressor NKX3.1 by the oncogenic protein kinase Pim-1 in prostate cancer cells.
Padmanabhan A; Gosc EB; Bieberich CJ
J Cell Biochem; 2013 May; 114(5):1050-7. PubMed ID: 23129228
[TBL] [Abstract][Full Text] [Related]
5. Nkx3.1 functions as para-transcription factor to regulate gene expression and cell proliferation in non-cell autonomous manner.
Zhou J; Qin L; Tien JC; Gao L; Chen X; Wang F; Hsieh JT; Xu J
J Biol Chem; 2012 May; 287(21):17248-17256. PubMed ID: 22465996
[TBL] [Abstract][Full Text] [Related]
6. Regulating NKX3.1 stability and function: Post-translational modifications and structural determinants.
Padmanabhan A; Rao V; De Marzo AM; Bieberich CJ
Prostate; 2016 May; 76(6):523-33. PubMed ID: 26841725
[TBL] [Abstract][Full Text] [Related]
7. The Tumor Suppressor NKX3.1 Is Targeted for Degradation by DYRK1B Kinase.
Song LN; Silva J; Koller A; Rosenthal A; Chen EI; Gelmann EP
Mol Cancer Res; 2015 May; 13(5):913-22. PubMed ID: 25777618
[TBL] [Abstract][Full Text] [Related]
8. Functional activation of ATM by the prostate cancer suppressor NKX3.1.
Bowen C; Ju JH; Lee JH; Paull TT; Gelmann EP
Cell Rep; 2013 Aug; 4(3):516-29. PubMed ID: 23890999
[TBL] [Abstract][Full Text] [Related]
9. WW domain-containing E3 ubiquitin protein ligase 1 targets p63 transcription factor for ubiquitin-mediated proteasomal degradation and regulates apoptosis.
Li Y; Zhou Z; Chen C
Cell Death Differ; 2008 Dec; 15(12):1941-51. PubMed ID: 18806757
[TBL] [Abstract][Full Text] [Related]
10. Loss of PTEN Accelerates NKX3.1 Degradation to Promote Prostate Cancer Progression.
Bowen C; Ostrowski MC; Leone G; Gelmann EP
Cancer Res; 2019 Aug; 79(16):4124-4134. PubMed ID: 31213464
[No Abstract] [Full Text] [Related]
11. Two Degradation Pathways of the p35 Cdk5 (Cyclin-dependent Kinase) Activation Subunit, Dependent and Independent of Ubiquitination.
Takasugi T; Minegishi S; Asada A; Saito T; Kawahara H; Hisanaga S
J Biol Chem; 2016 Feb; 291(9):4649-57. PubMed ID: 26631721
[TBL] [Abstract][Full Text] [Related]
12. NKX3.1 is regulated by protein kinase CK2 in prostate tumor cells.
Li X; Guan B; Maghami S; Bieberich CJ
Mol Cell Biol; 2006 Apr; 26(8):3008-17. PubMed ID: 16581776
[TBL] [Abstract][Full Text] [Related]
13. CRISPR/Cas9-Mediated Point Mutation in
Bowen C; Shibata M; Zhang H; Bergren SK; Shen MM; Gelmann EP
Cancer Res; 2020 Nov; 80(21):4805-4814. PubMed ID: 32943441
[No Abstract] [Full Text] [Related]
14. Hedgehog signaling promotes the degradation of tumor suppressor Sufu through the ubiquitin-proteasome pathway.
Yue S; Chen Y; Cheng SY
Oncogene; 2009 Jan; 28(4):492-9. PubMed ID: 18997815
[TBL] [Abstract][Full Text] [Related]
15. Expression of Nkx3.1 enhances 17beta-estradiol anti-tumor action in PC3 human prostate cancer cells.
Wang P; Liu B; Luo JD; Zhang ZG; Ma Q; Chen ZD
Asian J Androl; 2007 May; 9(3):353-60. PubMed ID: 17486276
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional regulation of the homeobox gene NKX3.1 by all-trans retinoic acid in prostate cancer cells.
Thomas MA; Hodgson MC; Loermans SD; Hooper J; Endersby R; Bentel JM
J Cell Biochem; 2006 Dec; 99(5):1409-19. PubMed ID: 16817226
[TBL] [Abstract][Full Text] [Related]
17. Nkx3.1 and p27(KIP1) cooperate in proliferation inhibition and apoptosis induction in human androgen-independent prostate cancer cells.
Wang P; Ma Q; Luo J; Liu B; Tan F; Zhang Z; Chen Z
Cancer Invest; 2009 May; 27(4):369-75. PubMed ID: 19266349
[TBL] [Abstract][Full Text] [Related]
18. CK2 mediates phosphorylation and ubiquitin-mediated degradation of the PML tumor suppressor.
Scaglioni PP; Yung TM; Choi S; Baldini C; Konstantinidou G; Pandolfi PP
Mol Cell Biochem; 2008 Sep; 316(1-2):149-54. PubMed ID: 18566754
[TBL] [Abstract][Full Text] [Related]
19. Haploinsufficient prostate tumor suppression by Nkx3.1: a role for chromatin accessibility in dosage-sensitive gene regulation.
Mogal AP; van der Meer R; Crooke PS; Abdulkadir SA
J Biol Chem; 2007 Aug; 282(35):25790-800. PubMed ID: 17602165
[TBL] [Abstract][Full Text] [Related]
20. Phosphorylation of the homeotic tumor suppressor Cdx2 mediates its ubiquitin-dependent proteasome degradation.
Gross I; Lhermitte B; Domon-Dell C; Duluc I; Martin E; Gaiddon C; Kedinger M; Freund JN
Oncogene; 2005 Dec; 24(54):7955-63. PubMed ID: 16027724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]